Aqeel Siddiqui, MD
Vascular Surgery · Brockton, MANPI 1164416186
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,532 of the $8,942 with a category attached, or 61.9%. 29 manufacturers reported payments, led by Penumbra, Inc. at 31.2% of the total. Reporting peaked in 2019 at $2,598 and has fallen 80.9% since, to $496 in 2025.
Across 165 payments — averaging $54.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$3K
- Lemaitre Vascular, Inc.$2K
- Boston Scientific$831
- Smith+Nephew$731
- Medtronic$326
- Endologix LLC$271
- plus $2K from 23 others
What the payments were for
- Consulting fees$2,37527%
- Speaking & faculty fees$881%
- Travel & lodging$89410%
- Food & beverage$5,53262%
- Education$541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 26 | $2,787 |
| Lemaitre Vascular, Inc. | 9 | $2,475 |
| Boston Scientific | 36 | $831 |
| Smith+Nephew | 44 | $731 |
| Medtronic | 6 | $326 |
| Endologix LLC | 1 | $271 |
| Johnson & Johnson | 10 | $242 |
| Silk Road Medical, Inc. | 2 | $188 |
| W. L. Gore & Associates, Inc. | 1 | $161 |
| Integra Lifesciences Corporation | 7 | $134 |
| Sanara Medtech Inc. | 1 | $104 |
| Madrigal Pharmaceuticals | 1 | $90 |
| Organogenesis Inc. | 1 | $88 |
| Cardiovascular Systems Inc. | 2 | $86 |
| Bolton Medical Inc | 2 | $85 |
| Terumo Medical Corporation | 2 | $57 |
| Cook Medical LLC | 2 | $35 |
| Mozarc Medical US LLC | 1 | $29 |
| Cormedix Inc. | 1 | $26 |
| Angiodynamics, Inc. | 1 | $26 |
| Innovation Technologies Inc | 1 | $23 |
| Advanced Oxygen Therapy Inc. | 1 | $22 |
| Polynovo North America LLC | 1 | $21 |
| Urgo Medical North America, LLC | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $20 |
| Surmodics, Inc. | 1 | $19 |
| Edwards Lifesciences | 1 | $17 |
| Reprise Biomedical, Inc. | 1 | $16 |
| Reflow Medical Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo$1,506
- TRIVEX$1,000
- Indigo System$843
- ANASTOCLIP$500
- XENOSURE BIOLOGIC PATCH$500
- VALVULOTOM$375
- Penumbra System$248
- ENHANCE Transcarotid Peripheral Access Kit$171
- ENROUTE Transcarotid Stent$171
- ENROUTE .014 Guidewire$171
- ENROUTE Transcarotid Neuroprotection System$171
- ELLIPSYS VASCULAR ACCESS SYSTEM$171
- ACUSEAL Vascular Graft$161
- GRAFIX PL$146
- RUBY Coil$135
- CellerateRx$104
How this compares
$8,942 in reported general payments places this provider in the 70th percentile of 142 vascular surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 40 | $35,121 |
| XareltoRivaroxaban | 14 | $19,875 |
| ClopidogrelClopidogrel Bisulfate | 99 | $1,377 |
| Gentamicin Sulfate | 27 | $902 |
| Betamethasone Dipropionate | 24 | $887 |
| Doxycycline Hyclate | 28 | $228 |
| Gabapentin | 23 | $191 |
| Oxycodone Hcl | 24 | $94 |
| Prednisone | 16 | $62 |
| Tramadol Hcl | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $242 | $19,87514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 142 vascular surgery providers in Massachusetts.
Other vascular surgery in Brockton
- Alicia StaffordBrockton$7K
- Mark KulbaskiBrockton$6K
- Thomas OdonnellBoston$845K
- Scott JamesPlymouth$199K
- Anahita DuaBoston$186K
- Dejah JudelsonWorcester$92K
- Jonathan GertlerWeston$90K
- Andres SchanzerWorcester$84K
- Richard PinNorth Dartmouth$73K
- Marc SchermerhornBoston$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.